“Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache”, Bangladesh J Pharmacol, vol. 11, no. 2, pp. 428–432, Apr. 2016, doi: 10.3329/bjp.v11i2.26333.